PREVIEW-MannKind faces crucial test; many bet it will fail | Reuters

Links shared publicly online about this topic.

  • 1,476
    total visits

PREVIEW-MannKind faces crucial test; many bet it will fail | Reuters

reuters.com

* MannKind prepares for FDA ruling on insulin device * FDA set to rule on Afresa approval by Jan. 16 * Many on Wall St skeptical drug will be approved By Toni Clarke BOSTON, Jan 5 (Reuters) - MannKind

View full resource at reuters.com

Tags: Diabetes, Diabetes Medication, Insulin, Drug, FDA, Afresa

  • Share

Most Recently Shared on January 6, 2010 at 12:57 pm By:

PREVIEW-MannKind faces crucial test; many bet it will fail | Reuters

reuters.com — “* MannKind prepares for FDA ruling on insulin device * FDA set to rule on Afresa approval by Jan. 16 * Many on Wall St skeptical drug will be approved By Toni Clarke BOSTON, Jan 5 (Reuters) - MannKindView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 5, 2010 at 11:03 pm By:

ReutersLisaRx Lisa Richwine Health Communicator

Will MannKind's inhaled insulin get past the "ghost of Exubera" to win FDA approval? Decision due Jan 16 http://link.reuters.com/fup89g

2 years ago...

Advertisement